castle trial demographics
Expose 5 Biases in Chronic Disease Management Data
The CASTLE trial, which enrolled 212 participants, exposes five key biases in chronic disease management data - age, gender, ethnicity, disease severity, and prior-therapy exposure - highlighting how each can skew perceived efficacy of CD19 CAR-T for autoimmune conditions. Medical Disclaimer: This article is for informational purposes only and does